[go: up one dir, main page]

DK0617623T3 - Acetylsalicylsyreholdigt transdermalt indgivelsessystem til antithrombotisk behandling - Google Patents

Acetylsalicylsyreholdigt transdermalt indgivelsessystem til antithrombotisk behandling

Info

Publication number
DK0617623T3
DK0617623T3 DK93900057T DK93900057T DK0617623T3 DK 0617623 T3 DK0617623 T3 DK 0617623T3 DK 93900057 T DK93900057 T DK 93900057T DK 93900057 T DK93900057 T DK 93900057T DK 0617623 T3 DK0617623 T3 DK 0617623T3
Authority
DK
Denmark
Prior art keywords
acetylsalicylic acid
transdermal administration
administration system
containing transdermal
antithrombotic treatment
Prior art date
Application number
DK93900057T
Other languages
English (en)
Inventor
Frank Becher
Thomas Kissel
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK0617623T3 publication Critical patent/DK0617623T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK93900057T 1991-12-20 1992-12-16 Acetylsalicylsyreholdigt transdermalt indgivelsessystem til antithrombotisk behandling DK0617623T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4142483 1991-12-20
PCT/EP1992/002914 WO1993012799A1 (de) 1991-12-20 1992-12-16 Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe

Publications (1)

Publication Number Publication Date
DK0617623T3 true DK0617623T3 (da) 2002-09-09

Family

ID=6447817

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93900057T DK0617623T3 (da) 1991-12-20 1992-12-16 Acetylsalicylsyreholdigt transdermalt indgivelsessystem til antithrombotisk behandling

Country Status (23)

Country Link
US (2) US6264978B1 (da)
EP (1) EP0617623B1 (da)
JP (1) JP3748270B2 (da)
KR (2) KR100267442B1 (da)
AT (1) ATE217528T1 (da)
AU (1) AU667067B2 (da)
CA (1) CA2125662C (da)
CZ (1) CZ285190B6 (da)
DE (2) DE4241128C2 (da)
DK (1) DK0617623T3 (da)
ES (1) ES2176197T3 (da)
FI (1) FI113838B (da)
HR (1) HRP921157A2 (da)
HU (1) HU221679B1 (da)
IL (1) IL103917A (da)
NO (1) NO306599B1 (da)
NZ (1) NZ246158A (da)
PT (1) PT617623E (da)
SI (1) SI9200312A (da)
SK (1) SK67094A3 (da)
WO (1) WO1993012799A1 (da)
YU (1) YU75093A (da)
ZA (1) ZA922814B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240917A (en) * 1991-04-03 1993-08-31 Keimowitz Rudolph M Suppression of thromboxane levels by percutaneous administration of aspirin
WO1994013302A1 (de) * 1991-12-20 1994-06-23 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe
US6071896A (en) * 1992-06-16 2000-06-06 Gundersen Clinic, Ltd. Suppression of thromboxane levels by percutaneous administration of aspirin
EP0671916A1 (de) * 1992-12-07 1995-09-20 LTS Lohmann Therapie-Systeme GmbH & Co. KG Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
DE4429663C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Hydrolyseschutz
AU6708996A (en) * 1995-07-27 1997-02-26 Cal International Limited Transdermal nitrate formulation
AU6709196A (en) * 1995-07-27 1997-02-26 Cal International Limited Transdermal patch containing aspirin
AU6709096A (en) * 1995-07-27 1997-02-26 Cal International Limited Pharmaceutical preparation for percutaneous absorbtion
EP0784975B1 (en) * 1995-12-26 2005-10-19 Teikoku Seiyaku Kabushiki Kaisha Use of acetylsalicylic acid in the manufacture of a drug for the treatment of skin injuries
DE19601487C2 (de) * 1996-01-17 2001-09-13 Micronas Gmbh Vorrichtung zum Behandeln von malignen Gewebsveränderungen
JPH1112177A (ja) * 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤
DE19949252B4 (de) * 1999-10-13 2004-02-12 Lts Lohmann Therapie-Systeme Ag Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung
JP2001187739A (ja) * 1999-12-28 2001-07-10 Teikoku Seiyaku Co Ltd アレルギー性皮膚疾患治療用外用剤
RU2201234C2 (ru) * 2000-12-05 2003-03-27 Воронежский государственный университет Полимерный водорастворимый аналог ацетилсалициловой кислоты и способ его получения
WO2003018023A1 (en) * 2001-08-23 2003-03-06 Bruce Frome Compositions and methods for targeting cerebral circulation and treatment of headache
US20040248858A1 (en) * 2003-06-09 2004-12-09 Parghi Kaumil H. Cure for cancer
US20060127463A1 (en) * 2004-12-15 2006-06-15 Nugara Peter N Composite structure including a low vinyl acetate layer
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
EP2610242A1 (en) 2006-07-09 2013-07-03 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of aspirin
CN101688370A (zh) * 2007-05-09 2010-03-31 巴科曼实验室国际公司 用于纸或纸板的烯基琥珀酸酐施胶乳液
WO2008149181A1 (en) * 2007-06-04 2008-12-11 Techfields Inc Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
WO2010065936A1 (en) 2008-12-04 2010-06-10 Chongxi Yu High penetration compositions and their applications
WO2011076401A1 (de) 2009-12-23 2011-06-30 Holger Schankin Acetylsalicylsäure-haltige, im wesentlichen wasserfreie pharmazeutische zusammensetzungen
CN104540504A (zh) 2012-01-18 2015-04-22 苏州泰飞尔医药有限公司 治疗肺部疾病的高穿透力前药组合物和医药组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
FR2297612A1 (fr) 1975-01-20 1976-08-13 Moorleghem Guy Van Procede de fabrication d'un produit analgesique a usage externe
US4012508A (en) 1975-02-03 1977-03-15 Burton Verna M Topical composition and method
US4219548A (en) 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
FR2496459A1 (fr) 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
US4460368A (en) * 1981-10-29 1984-07-17 Almedco, Inc. Trans-dermal medication system
IL68965A (en) 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
US4640689A (en) 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
DE3583698D1 (de) 1984-04-23 1991-09-12 Kao Corp Perkutaner absorptions-beschleuniger und diesen enthaltendes praeparat.
JPS61167615A (ja) 1985-01-18 1986-07-29 Teisan Seiyaku Kk 薬剤投与方法
US4810699A (en) 1987-02-20 1989-03-07 American Home Products Corporation Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them
JPH01203336A (ja) 1988-02-09 1989-08-16 Teikoku Seiyaku Kk 経皮・口腔粘膜適用製剤
JPH01242521A (ja) 1988-03-23 1989-09-27 Nikko Kemikaruzu Kk 経皮吸収性を高めた消炎鎮痛薬組成物
US4975269A (en) 1989-07-31 1990-12-04 Leonard Chavkin Shelf stable aspirin solutions
AU668352B2 (en) 1991-04-03 1996-05-02 Keimowitz, Rudolph M.D. Suppression of thromboxane levels by percutaneous administration of aspirin

Also Published As

Publication number Publication date
NO306599B1 (no) 1999-11-29
HRP921157A2 (en) 1994-10-31
HUT74559A (en) 1997-01-28
DE4241128A1 (en) 1993-06-24
DE4241128C2 (de) 1996-05-23
DE59209956D1 (de) 2002-06-20
IL103917A (en) 1996-09-12
AU3158993A (en) 1993-07-28
FI942922L (fi) 1994-06-17
JP3748270B2 (ja) 2006-02-22
SK67094A3 (en) 1995-03-08
KR950703972A (ko) 1995-11-17
CZ145694A3 (en) 1995-01-18
ES2176197T3 (es) 2002-12-01
US6264978B1 (en) 2001-07-24
FI942922A0 (fi) 1994-06-17
YU75093A (sh) 1997-08-22
AU667067B2 (en) 1996-03-07
SI9200312A (en) 1993-06-30
NZ246158A (en) 1995-10-26
WO1993012799A1 (de) 1993-07-08
FI113838B (fi) 2004-06-30
CA2125662A1 (en) 1993-07-08
JPH07502521A (ja) 1995-03-16
NO942325L (no) 1994-06-17
NO942325D0 (no) 1994-06-17
HU9401849D0 (en) 1994-09-28
US5861170A (en) 1999-01-19
PT617623E (pt) 2002-10-31
CA2125662C (en) 2006-10-17
CZ285190B6 (cs) 1999-06-16
EP0617623A1 (de) 1994-10-05
EP0617623B1 (de) 2002-05-15
ZA922814B (en) 1993-06-23
ATE217528T1 (de) 2002-06-15
KR100267442B1 (ko) 2000-11-01
KR100267359B1 (ko) 2000-11-01
HU221679B1 (hu) 2002-12-28
IL103917A0 (en) 1993-04-04

Similar Documents

Publication Publication Date Title
DK0617623T3 (da) Acetylsalicylsyreholdigt transdermalt indgivelsessystem til antithrombotisk behandling
NO923769D0 (no) System for iontoforetisk tilfoersel av et medikament
GEP20063773B (en) Steroid Sulphatase Inhibitors
MY100721A (en) Therapeutic agent.
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
ATE117548T1 (de) Pharmazeutische zubereitungen zur verhütung von arzneimitteltoleranz.
IS1858B (is) Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
EP1032605A4 (en) POLYANHYDERS WITH DEGRADATION PRODUCTS THERAPEUTICALLY USED
YU126186A (en) Process for making water gelating solutions of arylpropionic acid derivatives, which can be respirated through skin
ATE96308T1 (de) Dosierform fuer verabreichung in der humanmedizin.
NO923859L (no) Medikament
FI961282L (fi) Transdermaalinen terapeuttinen systeemi, jossa on asetyylisalisyylihappo vaikuttavana aineena
ES2043744T3 (es) Sistema de suministro transdermico de procaterol.
AU3401093A (en) Therapeutic agent for threatened abortion
CA2331414A1 (en) Transdermal therapeutic system for the administration of candesartan
NO952234L (no) Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft
WO2001041771A3 (de) Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne
NO308195B1 (no) Anvendelse av benzydamin til fremstilling av et legemiddel ved behandling av patologiske tilstander forÕrsaket av TNF
RU95109228A (ru) Способ лечения трофических язв
DK192487A (da) Carbiovasculaere farmaceutiske praeparater, som er egnet til topisk indgivning
PL332035A1 (en) Transdermal therapeutic system including an estriol-containing composition of active substances
UA29005A (uk) Спосіб лікування трофічних виразок нижніх кінцівок
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi